🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The CHIP-AML22 Master protocol has the overall aim of increasing the cure r...
Status
Recruiting
Location
Princess Máxima Center for pediatric oncology
Start Date
2024-02-06
Trial ID
NCT06262438
This pilot study is evaluating how well pembrolizumab and combination chemo...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-11-24
Trial ID
NCT04383743
This study is open-label, multi-center, prospective study, which targets ch...
Status
Recruiting
Location
Kyungpook National University Chilgok Hospital
Start Date
2024-04-04
Trial ID
NCT05827549
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of chemoth...
Status
Unknown
Location
Lijuan Deng
Start Date
2014-05
Trial ID
NCT02399189
Treatments Being Tested
Rheumatoid Arthritis (RA) is an autoimmune disease that results in a chroni...
Status
Unknown
Location
Guang'anmen Hospital
Start Date
2017-10-28
Trial ID
NCT03337815
Treatments Being Tested
It is expected that addition of anti-CD20 antibody - ofatumumab would enhan...
Status
Completed
Location
Dolnośląskie Centrum Transplantacji Komórkowych
Start Date
2011-11
Trial ID
NCT01481272
This phase III trial compares the effect of usual treatment of chemotherapy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-01-25
Trial ID
NCT04530565
Treatments Being Tested
The goal of this clinical research study is to learn if intensive chemother...
Status
Completed
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2002-08
Trial ID
NCT00669877
Treatments Being Tested
This is an open label study to assess the improvement in the Disease Activi...
Status
Completed
Location
New York University School of Medicine
Start Date
2016-11-15
Trial ID
NCT02874092
Treatments Being Tested
Secondary central nervous system lymphoma (SCNSL) occurred in about 5% of p...
Status
Unknown
Location
Peking University Cancer Hospital & Institute
Start Date
2021-02-26
Trial ID
NCT05398224
Treatments Being Tested